On his first day in office, President Trump proposed significant tariffs, including a 25% tariff on imports from Mexico and Canada and a 60% tariff on Chinese goods. These tariffs, set to begin on February 1, could raise the prices of imported goods, particularly medications. Many affordable drugs and their ingredients are sourced from these countries, and tariffs could disrupt the current pricing structure that allows for lower costs in the US. Despite previous claims, experts highlight a likelihood of increased consumer costs for essential medications as a consequence of these trade policies.
Trump's tariff plans could raise the costs of medications for Americans as proposals include a 25% tariff on Mexico and Canada, impacting access to affordable treatments.
Experts warn that broad tariffs on trading partners like Canada and Mexico may increase prices of goods, affecting key medications used in the US.
Collection
[
|
...
]